News

MCTD May Be Subset of Systemic Scleroderma


 

EXPERT ANALYSIS FROM THE CONGRESS OF CLINICAL RHEUMATOLOGY

Also, as in scleroderma, the pulmonary vessels – even in patients who didn’t have pulmonary hypertension – had similar but less extensive disease, she added.

Based on these various findings, which together show a great deal of similarity to scleroderma while highlighting numerous differences from other connective tissue diseases, Dr. Steen said she is increasingly convinced that MCTD is not a unique entity, mixed disease, or subset of lupus, but is actually a subset of systemic scleroderma.

Dr. Steen reported having no disclosures relevant to her presentation.

Pages

Recommended Reading

Could a Urine Test Predict Response to Biologics?
MDedge Dermatology
ACR Releases Updated Lupus Nephritis Guidelines
MDedge Dermatology
ACR Gives Special Consideration to Pregnancy in Nephritis Guidelines
MDedge Dermatology
Scleroderma Malignancy Risk Linked to Antinuclear Antibodies
MDedge Dermatology
Digital Ulcer Disease in Systemic Sclerosis
MDedge Dermatology
Running, Aerobics May Protect Women Against Psoriasis
MDedge Dermatology
Gene Shields Psoriasis Patients from Heart Disease
MDedge Dermatology
Psoriasis Boosts Crohn's Risk Fourfold
MDedge Dermatology
High-Dose Ustekinumab Stomps Out Palmoplantar Psoriasis
MDedge Dermatology
Physical Therapy Only Option for Skin Thickening in Scleroderma
MDedge Dermatology